Exchange: NASDAQ Sector: Healthcare Industry: Medical Instruments & Supplies
Current Signal: SELL (auto-tracking)
-0.20% $74.03
America/New_York / 24 apr 2024 @ 16:00
FUNDAMENTALS | |
---|---|
MarketCap: | 4 288.56 mill |
EPS: | 1.620 |
P/E: | 45.70 |
Earnings Date: | Apr 30, 2024 |
SharesOutstanding: | 57.93 mill |
Avg Daily Volume: | 0.406 mill |
RATING 2024-04-24 |
---|
S- |
Strong Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Buy | |
Return On Asset: | Buy | |
DE: | Strong Buy | |
P/E: | Strong Buy | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 45.70 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
1.38x |
Company: PE 45.70 | industry: PE 33.06 |
DISCOUNTED CASH FLOW VALUE |
---|
$39.48 (-46.67%) $-34.55 |
Date: 2024-04-25 |
Expected Trading Range (DAY) |
---|
$ 72.36 - 75.70 ( +/- 2.26%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-14 | Lloyd Brian G. | Sell | 1 180 | Common Stock, No Par Value |
2024-03-12 | Parra Raul Jr. | Sell | 301 | Common Stock, No Par Value |
2024-03-12 | Parra Raul Jr. | Sell | 6 179 | Common Stock, No Par Value |
2024-03-07 | Wright Joseph | Buy | 25 000 | Common Stock, No Par Value |
2024-03-07 | Wright Joseph | Sell | 25 000 | Common Stock, No Par Value |
INSIDER POWER |
---|
8.39 |
Last 97 transactions |
Buy: 680 044 | Sell: 563 270 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $74.03 (-0.20% ) |
Volume | 0.238 mill |
Avg. Vol. | 0.406 mill |
% of Avg. Vol | 58.63 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $79.17 | N/A | Active |
---|
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.